$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
How much does ruxolitinib cream (Opzelura) cost and price comparison across different channels
2026-02-01 22:25:32
Check Details
Analysis of which country Epclusa is produced in and its drug research and development background
2026-02-01 22:25:32
Check Details
Analysis of the scope of indications and main diseases treated by Sunitinib (Sutent)
2026-02-01 22:25:32
Check Details
Tazerestat (Taveco) dosage, usage and daily medication instructions
2026-02-01 22:25:32
Check Details
Analysis on whether ceritinib/ceritinib (Zanda) can be stopped at will while taking the medicine
2026-02-01 22:25:32
Check Details
Analysis of the efficacy of Bestifan (Viliru) in the treatment of renal cancer and actual patient feedback
2026-02-01 22:25:32
Check Details
Analysis of the treatment plan of dabrafenib (Tefila) combined with trametinib in patients with BRAF mutation
2026-02-01 22:25:32
Check Details
Detailed description of which diseases and tumor types Axitinib (Inlida) mainly treats
2026-02-01 22:25:32
Check Details
The correct way to take Trametinib (Megenin) and the recommended dosage time and intervals
2026-02-01 22:25:32
Check Details
The launch time and indications of brigatinib/brigatinib in the country
2026-02-01 22:25:32
Check Details
Detailed instructions for Entrectinib/Luo Shengquan
2026-02-01 22:25:32
Check Details
Is acotinib/acalabrutinib officially launched in China and when will it be launched?
2026-02-01 22:25:32
Check Details
1
2
...
2025
2026
2027
2028
2029
2030
2031
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma